/PRNewswire/ Neurophth Therapeutics, Inc. ("Neurophth"), a China s leading gene therapy company for ophthalmic diseases, announced the closing of nearly 95.
San Diego-based Neurophth, a gene therapy company, has raised $60M in a Series C funding round, the company said today. The funding was co-led by CMG-SDIC Capital and Sequoia Capital China, and also incl